Contract SPE2D223D0002
Radha Pharmaceuticals Inc · Department Of Defense · September 13, 2024
Radha Pharmaceuticals Inc was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on September 13, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 15, 2025. If all options are exercised, the contract could reach $23.28 million.
Contract details
- PIID
- SPE2D223D0002
- Award type
- Indefinite Delivery / Requirements
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 13, 2024
- Latest action
- September 15, 2025
Description
4610095053!
Modification timeline
-
September 15, 2025Mod P00008 · Exercise An Option$0
-
April 22, 2025Mod P00007$0
-
September 13, 2024Mod P00006 · Exercise An Option4610095053!MANUFACTURE/DISTRIBUTOR BR-PH$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $51 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $91 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $32 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $1.1K |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $22 |
| Cardinal Health, Inc. | Department Of Defense | December 31, 2025 | $23 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract SPE2D223D0002?
Contract SPE2D223D0002 is a federal contract awarded to Radha Pharmaceuticals Inc by Department Of Defense on September 13, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract SPE2D223D0002?
Radha Pharmaceuticals Inc won contract SPE2D223D0002 from Department Of Defense.
How much is contract SPE2D223D0002 worth?
Contract SPE2D223D0002 has obligated $0 to date but carries a potential ceiling of $23.28 million if fully funded and all options are exercised.